Healthcare/Biotech
|
Updated on 04 Nov 2025, 10:01 am
Reviewed By
Satyam Jha | Whalesbook News Team
▶
Dr Agarwal's Healthcare has expressed strong confidence in its outlook, projecting a 20% growth in both revenue and profit for the current fiscal year. This optimism is supported by robust first-quarter results, which saw net profit surge by 88% year-over-year to ₹75 crore, driven by efficient operations, ongoing facility additions, and effective cost management.
Brokerage firms remain constructive on the company. Motilal Oswal highlights the potential synergies from the ongoing amalgamation of Dr Agarwal's Eye Hospital with its parent, Dr Agarwal's Healthcare, along with growth in premium eye care services and network expansion.
In the second quarter of the fiscal year, while revenues met expectations, earnings surpassed estimates. EBITDA margins expanded to 27%, beating a 26% estimate, primarily due to reduced raw material and employee costs. Net profit for the September quarter stood at ₹30 crore, up from ₹16 crore a year ago, benefiting from improved operations, lower finance costs, and a reduced tax rate.
Jefferies anticipates significant physical expansion, expecting Dr Agarwal's Healthcare to add 54 new facilities this fiscal year, marking a 24% increase. A substantial portion of this expansion, 33 centers, is planned for South India. The company is also seeing a strong start in the Delhi market and plans to considerably scale its presence there within the next 12 months.
Management indicated that while EBITDA is expected to be slightly stronger in the second half of the year, margin percentages are likely to remain around 26% as the company continues its investment in greenfield expansions.
Impact: This news suggests significant growth potential for Dr Agarwal's Healthcare, driven by both organic expansion and potential merger benefits. This could lead to positive stock performance and increased investor interest in the eye care sector in India. Rating: 8/10
Difficult Terms: Fiscal Year: A 12-month period that companies use for accounting and financial reporting, which may not coincide with the calendar year (January-December). Year-over-year (YoY): A comparison of financial data over a period with the data from the same period in the previous year. Net Profit: The profit remaining after all expenses and taxes have been deducted from total revenue. EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a company's operating performance. EBITDA Margins: Calculated as EBITDA divided by revenue, expressed as a percentage. It indicates profitability from core operations. Basis Points (bps): A unit of measure equal to one-hundredth of a percent (0.01%). 100 basis points equal 1 percent. Scheme of Amalgamation: A legal process where two or more companies merge into one. Going Concern: A business that is assumed to continue operating indefinitely into the future. Greenfield Expansion: Establishing a new business or facility from scratch in a location where there was no previous business activity.
Healthcare/Biotech
Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion
Healthcare/Biotech
Glenmark Pharma US arm to launch injection to control excess acid production in body
Healthcare/Biotech
IKS Health Q2 FY26: Why is it a good long-term compounder?
Healthcare/Biotech
Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure
Healthcare/Biotech
CGHS beneficiary families eligible for Rs 10 lakh Ayushman Bharat healthcare coverage, but with THESE conditions
Healthcare/Biotech
Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth
Energy
Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?
Banking/Finance
ED’s property attachment won’t affect business operations: Reliance Group
Economy
SBI joins L&T in signaling revival of private capex
Industrial Goods/Services
Berger Paints Q2 net falls 23.5% at ₹206.38 crore
Startups/VC
Fambo eyes nationwide expansion after ₹21.55 crore Series A funding
Mutual Funds
Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch
Tourism
MakeMyTrip’s ‘Travel Ka Muhurat’ maps India’s expanding travel footprint
Tourism
Radisson targeting 500 hotels; 50,000 workforce in India by 2030: Global Chief Development Officer
Chemicals
Jubilant Agri Q2 net profit soars 71% YoY; Board clears demerger and ₹50 cr capacity expansion